WED-240 Genomic and epigenomic profiling of hepatocellular carcinoma in liquid biopsy
Lauren Brotherton, Ning Wang, Maxwell Bladen, Jerick Guinto et autres
0 citationsJournal of Hepatology
Sarah Ftouni
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
71Publications signalées
2009Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Advanced Breast Cancer TherapiesOvarian cancer diagnosis and treatmentHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsCancer Treatment and Pharmacology
Publications récentes
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
Antonin Serrano, Tom Weber, Jean Berthelet, Sarah Ftouni et autres
0 citationsMolecular Systems Biology
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
Antonin Serrano, Tom Weber, Jean Berthelet, Sarah Ftouni et autres
1 citationbioRxiv (Cold Spring Harbor Laboratory)
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
Ing Soo Tiong, Tamia Nguyen, Chong Chyn Chua, Charis E. Teh et autres
4 citationsBlood Advances
Unravelling mutational signatures with plasma circulating tumour DNA
Sebastian Hollizeck, Ning Wang, Stephen Q. Wong, Cassandra Litchfield et autres
8 citationsNature Communications
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee et autres
15 citationsNature Communications
BAX Mutated Clonal Hematopoiesis Arises Following Treatment with the BCL2 Inhibitor Class of Therapeutics across a Range of Hematological and Non-Hematological Neoplasms
Ing Soo Tiong, Tamia Nguyen, Charis E. Teh, Chong Chyn Chua et autres
3 citationsBlood
Data from Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study
Peter Savas, Louisa L. Lo, Stephen J. Luen, Elizabeth F. Blackley et autres
0 citations
Data from Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study
Peter Savas, Louisa L. Lo, Stephen J. Luen, Elizabeth F. Blackley et autres
0 citations
Supplementary Data from Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study
Peter Savas, Louisa L. Lo, Stephen J. Luen, Elizabeth F. Blackley et autres
0 citations
Supplementary Data from Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study
Peter Savas, Louisa L. Lo, Stephen J. Luen, Elizabeth F. Blackley et autres
0 citations
Supplementary Figure from Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study
Peter Savas, Louisa L. Lo, Stephen J. Luen, Elizabeth F. Blackley et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.